Katsuya Nagaoka

17PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersMetabolic medicineMedical biochemistry - nucleic acidsMedical devicesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 18, 2026
Impact of Etiological Shifts and the Rising Burden of Non-B Non-C Hepatocellular Carcinoma on Surveillance and Prognosis: Insights From a 20-Year Retrospective Observational Study.

Yoko Yoshimaru, Katsuya Nagaoka, Hiroko Setoyama

|Nov 05, 2025
The Role of an Elevated Fibrosis-4 Index in Neurocognitive Decline and Brain Volume Reduction in Older Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Maiko Nagaoka, Katsuya Nagaoka, Naoto Kajitani

|Aug 19, 2025
Evaluation of fully automated chemiluminescent enzyme immunoassays for hepatitis B core-related antigen components, phosphorylated and non-phosphorylated hepatitis B core antigens: clinical significance and dynamics during hepatitis B e antigen seroconversion.

Takanori Suzuki, Chiharu Ohue, Osamu Arai

|May 28, 2025
Integrated hepatic ferroptosis gene signature dictates pathogenic features of ferroptosis.

|May 03, 2025
Serum alpha-fetoprotein/hepatocyte growth factor ratio as a novel biomarker predicting the prognosis of acute alcoholic hepatitis.

Hiroki Inada, Katsuya Nagaoka, Kenyu Hashimoto

|Mar 31, 2025
Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease.

Hongze Chen, Muhammad Azhar Nisar, Joud Mulla

Pageof 3

Frequent Collaborators

12 joint publications

Yasuhito Tanaka

4 joint publications

Takehisa Watanabe

4 joint publications

Takayuki Tokunaga

4 joint publications

Hiroki Inada